Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP288187.RAH7jiD8kasP54B-uLyxgwNdz9TlBs-J1IwOSeJRLJDyk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP288187.RAH7jiD8kasP54B-uLyxgwNdz9TlBs-J1IwOSeJRLJDyk130_assertion type Assertion NP288187.RAH7jiD8kasP54B-uLyxgwNdz9TlBs-J1IwOSeJRLJDyk130_head.
- NP288187.RAH7jiD8kasP54B-uLyxgwNdz9TlBs-J1IwOSeJRLJDyk130_assertion description "[Patients with INT2/HST1 amplified breast cancer had a significantly shorter disease-free survival compared to those with unamplified genes (P = 0.015, median follow up 45 months).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288187.RAH7jiD8kasP54B-uLyxgwNdz9TlBs-J1IwOSeJRLJDyk130_provenance.
- NP288187.RAH7jiD8kasP54B-uLyxgwNdz9TlBs-J1IwOSeJRLJDyk130_assertion evidence source_evidence_literature NP288187.RAH7jiD8kasP54B-uLyxgwNdz9TlBs-J1IwOSeJRLJDyk130_provenance.
- NP288187.RAH7jiD8kasP54B-uLyxgwNdz9TlBs-J1IwOSeJRLJDyk130_assertion SIO_000772 1989653 NP288187.RAH7jiD8kasP54B-uLyxgwNdz9TlBs-J1IwOSeJRLJDyk130_provenance.
- NP288187.RAH7jiD8kasP54B-uLyxgwNdz9TlBs-J1IwOSeJRLJDyk130_assertion wasDerivedFrom befree-20140225 NP288187.RAH7jiD8kasP54B-uLyxgwNdz9TlBs-J1IwOSeJRLJDyk130_provenance.
- NP288187.RAH7jiD8kasP54B-uLyxgwNdz9TlBs-J1IwOSeJRLJDyk130_assertion wasGeneratedBy ECO_0000203 NP288187.RAH7jiD8kasP54B-uLyxgwNdz9TlBs-J1IwOSeJRLJDyk130_provenance.